Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1370773 | Bioorganic & Medicinal Chemistry Letters | 2011 | 8 Pages |
We previously reported on a series of cyclohexanediamine derivatives as highly potent factor Xa inhibitors. Herein, we describe the modification of the spacer moiety to discover an alternative scaffold. Ethylenediamine derivatives possessing a substituent at the C1 position in S configuration and phenylenediamine derivatives possessing a substituent at the C5 position demonstrated moderate to strong anti-fXa activity. Further SAR studies led to the identification of compound 30h which showed both good in vitro activity (fXa IC50 = 2.2 nM, PTCT2 = 3.9 μM) and in vivo antithrombotic efficacy.
Graphical abstractA series of ethylenediamine and phenylenediamine derivatives were synthesized as factor Xa (fXa) inhibitors.Figure optionsDownload full-size imageDownload as PowerPoint slide